Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
released

Certificate of analysis

KPV

Lot CP-KPV-2604B · 20 mg

99.57 %

HPLC purity

Spec ≥ 99.0 %

90.4 %

Net peptide content

By amino acid analysis

< 0.64

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Janoshik Analytical
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
Apr 13, 2026
Release tested
Apr 22, 2026 (5 months ago)
Retest date
Apr 12, 2028
CAS number
67727-97-3
Molecular formula
C16H30N4O4
Theoretical mass
342.44 Da
Observed mass (LC-MS)
342.12 Da (Δ 0.32 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 99.0 %99.57 %Pass
LC-MS (ESI+)Identity — observed mass342.44 ± 1.0 Da342.12 DaPass
Amino acid analysisNet peptide content≥ 80.0 %90.4 %Pass
Karl FischerWater content≤ 8.0 %1.41 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.22 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.64 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Sequence

H-Lys-Pro-Val-OH

Handling for this lot

Appearance
White lyophilised powder
Storage
-20 °C lyophilised; stable at 2–8 °C reconstituted
Reconstitution
Straightforward — dissolves on contact with essentially any aqueous diluent.

Other lots of KPV

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.